Press Releases
Subscribe to our mailing list to receive the latest news.
To browse our press releases, simply click on the year that interests you to view the documents.
2020
June 2 - Neptune Appoints Robert DiPede as Senior Vice President of Biodroga and Health & Wellness Innovation
May 19 - Neptune Announces $16.5 Million Extraction Partnership for Hemp Processing at Sherbrooke Facility
Apr 9 - Neptune Successfully Completes Submission to U.S. FDA for Registration of its Conover, NC Facility for Production of Hand Sanitizers
Apr 8 - Neptune Announces Sherbrooke Phase II Expansion is Now Operational and Running Product for Customers
2019
Nov. 11 - Neptune Announces a Definitive Agreement with International Flavors & Fragrances to Co-Develop Hemp-Derived CBD Products
Oct. 28 - Neptune to Hold Conference Call to Discuss Second Quarter Results Ended September 30, 2019
June 17 - Neptune’s wholly owned subsidiary, 9354-7537 Québec Inc, Receives Health Canada’s Amendments to Expand Capacity to 200,000 kg and for Cannabis Oil Capsule Production
June 12 - Neptune Signs Multi-Year Extraction Agreement for 230,000 kg Including Turnkey Solutions with The Green Organic Dutchman
May 30 - Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year-End Results Ended March 31, 2019
Apr. 15 - Neptune Expands Existing Offering of Turnkey Solutions in the U.S. to Include Hemp Ingredients
Mar. 26 - Neptune’s wholly owned subsidiary, 9354-7537 Québec Inc, Begins Commercial Production and Shipping of Cannabis Extracts
2018
Oct. 31 - Neptune to Hold Conference Call to Discuss Second Quarter Results for the Three Months Period Ended September 30, 2018 Laval,
Jun. 19 - Neptune Announces Multi-year Agreement with Canopy Growth to Provide Extracted Cannabis Products
Mar. 31 - Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year-End Results Ended March 31, 2018
Feb. 12 - Neptune and Tetra Bio-Pharma Enter Co-Development Agreement for Purified Cannabinoid Oil-Based Products targeting Pain and Inflammation
Jan. 31 - Neptune to Hold Conference Call to Discuss Third Quarter Results for the Interim Period Ended December 31, 2017
2017
Neptune Receives Nasdaq Notification Confirming that it has Regained Compliance with Minimum Bid Requirements
Neptune to Hold Conference Call to Discuss Second Quarter Results for the Interim Period Ended September 30, 2017
Aker BioMarine and Neptune announce closing of $US34 million transaction to accelerate business and industry development
Neptune Announces Resignation of Pierre Fitzgibbon as a Director and the Appointment of John Moretz as Chairman
Neptune to Hold Conference Call to Discuss First Quarter Results for the Three Months Period Ended June 30, 2017
Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year-End Results for the Thirteen Months Period Ended March 31, 2017
Unique Medical Cannabis Partnership Announced, Creating Scientific and Business Development Hub in Sherbrooke, Quebec
Financial results
To browse our annual reports, simply click on the year that interests you to view the documents.
Annual and Quarterly Reports
2019
2018
2017
Events and Presentations
Neptune is committed to providing investors with timely and accurate information about our business strategy, operating performance and financial reporting. We participate in industry-sponsored conferences and events and also host conference calls and webcasts to review our financial and operating results.
Image
Neptune is driven by a passionate leadership team backed by years of industry experience and in-depth knowledge of pharmaceutical, biotech and nutritional supplements.
Image
The Board of Directors leads, governs and sets Neptune's strategic direction.
Neptune is guided by an experienced group of professionals who believe that strong corporate governance is essential for delivering sustainable value and achieving the company’s vision and objectives.
Image
Discover Neptune’s holistic approach to creating stakeholder value.
Image
